Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Lilyana Amezcua, MD

    TitleAssociate Professor of Clinical Neurology
    SchoolKeck School of Medicine of USC
    AddressGNH Eeg 4aye114
    Off Campus
    Los Angeles California 90089-9315
    Phone+1 323 409 3439
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Amezcua is a multiple sclerosis specialist trained under the direction of USC’s Dr. Leslie P. Weiner. She completed a residency in neurology and was chief resident. She was awarded a Multiple Sclerosis Fellowship by the National Multiple Sclerosis Society. Her research is focused on collaborating with basic researchers in the field of immunology, employing new imaging techniques to access disease progression, as well as defining racial disparities that may exist within the multiple sclerosis population. She is active within her community and lectures both in English and Spanish. Dr. Amezcua currently serves as co-investigator to several clinical trials within the MS department.

      Collapse Biography 
      Collapse Clinical Trials

      Collapse ORNG Applications 
      Collapse Featured Videos
      Collapse Required Scholarly Project Mentor

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology. 2017 Aug 30. PMID: 28855411.
        View in: PubMed
      2. Amezcua L, Nelson F. Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics. Neurotherapeutics. 2017 Aug 04. PMID: 28779373.
        View in: PubMed
      3. Obiwuru O, Joseph S, Liu L, Palomeque A, Tarlow L, Langer-Gould AM, Amezcua L. Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging. Int J MS Care. 2017 May-Jun; 19(3):131-139. PMID: 28603461.
        View in: PubMed
      4. Berkovich R, Bakshi R, Amezcua L, Axtell RC, Cen SY, Tauhid S, Neema M, Steinman L. Adrenocorticotropic hormone versus methylprednisolone added to interferon ß in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial. Ther Adv Neurol Disord. 2017 Jan; 10(1):3-17. PMID: 28450891.
        View in: PubMed
      5. Langille MM, Islam T, Burnett M, Amezcua L. Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans. J Child Neurol. 2016 Jul; 31(8):1068-73. PMID: 27021143.
        View in: PubMed
      6. Sahai-Srivastava S, Wang SL, Ugurlu C, Amezcua L. Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population. Clin Neurol Neurosurg. 2016 Apr; 143:71-5. PMID: 26896785.
        View in: PubMed
      7. Amezcua L, Morrow MJ, Jirawuthiworavong GV. Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies. Curr Opin Ophthalmol. 2015 Nov; 26(6):534-9. PMID: 26397889.
        View in: PubMed
      8. Ma KC, Fernandez JR, Amezcua L, Lerner A, Shiroishi MS, Liu BJ. Design and development of an ethnically-diverse imaging informatics-based eFolder system for multiple sclerosis patients. Comput Med Imaging Graph. 2015 Dec; 46 Pt 2:257-68. PMID: 26564667; PMCID: PMC4936902 [Available on 12/01/16].
      9. Khan O, Williams MJ, Amezcua L, Javed A, Larsen KE, Smrtka JM. Multiple sclerosis in US minority populations: Clinical practice insights. Neurol Clin Pract. 2015 Apr; 5(2):132-142. PMID: 26137421.
        View in: PubMed
      10. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015 Jan 21; 85(2):296-302. PMID: 25611508; PMCID: PMC4350773.
      11. Amezcua L, Conti DV, Liu L, Ledezma K, Langer-Goulda AM. Place of birth,age of immigration,and disability in Hispanics with multiple sclerosis. Mult Scler Relat Disord. 2015 Jan; 4(1):25-30. PMID: 25729639; PMCID: PMC4341972.
      12. Ebrahimi N, Herbstritt S, Gold R, Amezcua L, Koren G, Hellwig K. Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult Scler. 2015 Feb; 21(2):198-205. PMID: 25159275.
        View in: PubMed
      13. Zada G, Kintz N, Pulido M, Amezcua L. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One. 2013; 8(11):e76562. PMID: 24223703; PMCID: PMC3818366.
      14. Amezcua L, Lerner A, Ledezma K, Conti D, Law M, Weiner L, Langer-Gould A. Spinal cord lesions and disability in Hispanics with multiple sclerosis. J Neurol. 2013 Nov; 260(11):2770-6. PMID: 23912723; PMCID: PMC3816004.
      15. Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Vitamin D levels in Hispanics with multiple sclerosis. J Neurol. 2012 Dec; 259(12):2565-70. PMID: 22588255.
        View in: PubMed
      16. Amezcua L, Lund BT, Weiner LP, Islam T. Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler. 2011 Aug; 17(8):1010-6. PMID: 21467188.
        View in: PubMed
      17. Sahai-Srivastava S, Amezcua L. Compressive neuropathies complicating normal childbirth: case report and literature review. Birth. 2007 Jun; 34(2):173-5. PMID: 17542822.
        View in: PubMed